Scientists from the Academy of Sciences of China’s Virology Institute of Wuhan have developed an anti-flu vaccine with the use of nanotechnology.
The study’s team leader Cui Zongqiang shared that an intranasal kind of medication, administered by way of the nasal structures, has been developed in order to fight the viruses and to also strengthen the immune system of a person.
According to China Daily, the nano-vaccine is capable of targeting the broad spectrum of flu viruses. “The results suggest that the 3M2e-rHF nanoparticle is a promising, needle-free, intranasally administered, cross-protective influenza vaccine,” said Cui.
Cui shared that during their tests, the drug has proven to be effective in treating infections that are caused by virus H9N2 and H1N1 in mice. He also said that they have not used syringes in order to administer the vaccine to the mice. They recognized that China and other countries experience common cold outbreaks, especially during the winter season.
In December 2017 alone, there are about 11,200 influenza cases in China. This number is 71-percent higher compared to the recorded influenza cases three years ago. The scientists also understand that children are the group of people who are the worst-affected. China even confirmed last February 14 that they have the very first case of a person infected with the bird flu H7N4 virus, as reported by Latin American News Agency, Prensa Latina.